The pediatric committee, Pedimacs, evaluates special issues in the pediatric population receiving MCSD therapy, differences in devices available, and the particular pediatric population for whom this therapy may be most effective.  They provide expertise on the unique aspects of infants, children, and teenagers receiving MCSD therapy. Pedimacs is instrumental in the scientific analysis of pediatric data, and direct dissemination of results via abstracts, publications and other forms of media.
The committee investigates merging relationships with external registries and databases and developing future research projects.